Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E9NJ
|
|||
Former ID |
DIB006512
|
|||
Drug Name |
PARCETASAL
|
|||
Synonyms |
MR-897; Parcetasal; N-[4-(2-Methyl-4-oxo-1,3-benzodioxan-2-yloxy)phenyl]acetamide; Rac-4'-(2-Methyl-4-oxo-1,3-benzodioxan-2-yloxy)acetanilide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Inflammation [ICD-11: 1A00-CA43.1] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H15NO5
|
|||
Canonical SMILES |
CC(=O)NC1=CC=C(C=C1)OC2(OC3=CC=CC=C3C(=O)O2)C
|
|||
InChI |
1S/C17H15NO5/c1-11(19)18-12-7-9-13(10-8-12)21-17(2)22-15-6-4-3-5-14(15)16(20)23-17/h3-10H,1-2H3,(H,18,19)
|
|||
InChIKey |
ZAPRLADYRFPQSH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 87549-36-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin synthetase (PGS) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase. J Neurosci Res. 2003 Mar 15;71(6):844-52. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.